About Mersana Therapeutics, Inc. - Common Stock (MRSN)
Mersana Therapeutics is a biotechnology company focused on the development of innovative treatments for cancer. The company specializes in advancing antibody-drug conjugates (ADCs), which are targeted therapies designed to deliver potent cytotoxic agents directly to cancer cells while minimizing damage to healthy tissue. Mersana is dedicated to improving patient outcomes through its proprietary technology platform, which enables the design of highly effective treatments aimed at addressing various types of tumors. With a strong emphasis on research and development, the company is committed to bringing novel therapies to market that address unmet medical needs in the oncology space. Read More
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
